Irena W. H.
- Country
- Poland
- Department
- NA
Research Overview
- A Phase 1 Randomized, Double‑Blind, Placebo‑Controlled Study of BBT001 in Healthy Volunteers and Adults with Atopic Dermatitis
- Efficacy and Safety of Zasocitinib in Patients with Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ritlecitinib in Adults with Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 337 of 609 partner sites.
Specializations
Inflammatory Skin Conditions
Specializes in investigating novel treatments for chronic inflammatory dermatological conditions, with particular emphasis on atopic dermatitis and plaque psoriasis in both adult and pediatric populations.
- Atopic Dermatitis Management
- Pediatric Plaque Psoriasis
- Chronic Hand Eczema
Chronic Urticaria Research
Focuses on advancing therapeutic options for chronic spontaneous urticaria, evaluating multiple treatment modalities including novel biological therapies and small molecule inhibitors.
- Antihistamine-Resistant Urticaria
- Long-term Disease Management
- Novel Treatment Approaches
Complex Dermatological Disorders
Conducts research in challenging dermatological conditions including hidradenitis suppurativa, prurigo nodularis, and cutaneous lupus erythematosus.
- Hidradenitis Suppurativa Treatments
- Autoimmune Skin Conditions
- Rare Dermatological Diseases
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
